產(chǎn)品描述

        塔望科技深耕氣體濃度控制領(lǐng)域，基于成熟的高原環(huán)境模擬技術(shù)，拓展開(kāi)發(fā)適用于豬、羊、馬等大型動(dòng)物或大規(guī)模實(shí)驗(yàn)的ProOx-811XL可步入式低壓氧艙。該艙型不僅保障基礎(chǔ)功能(支持8000米低壓環(huán)境模擬及當(dāng)?shù)睾０蝿?dòng)態(tài)擬合)，更適配多元環(huán)境條件(如靈活的輻照與光照模擬、長(zhǎng)達(dá)90天的連續(xù)穩(wěn)定運(yùn)行)。通過(guò)優(yōu)化艙體材質(zhì)結(jié)構(gòu)、搭載精密通風(fēng)及控制系統(tǒng)，確保野外環(huán)境下無(wú)限接近真實(shí)的實(shí)驗(yàn)條件，可增配UPS、室外電源與防雷系統(tǒng)，為實(shí)地研究保駕護(hù)航。作為高原醫(yī)學(xué)、航天醫(yī)學(xué)及藥物研發(fā)的專(zhuān)業(yè)工具，該艙型支持人員進(jìn)入及多種聯(lián)合實(shí)驗(yàn)單元(如能量代謝、呼吸肺功能研究)，為多種環(huán)境下的疾病機(jī)制研究與藥物篩選提供了高效、全面的解決方案。

產(chǎn)品特點(diǎn)

1.精準(zhǔn)海拔控制（誤差≤±100m）

• 保障實(shí)驗(yàn)數(shù)據(jù)重復(fù)性，避免海拔偏差導(dǎo)致的結(jié)果失真

• 可模擬 8000 米海拔高度，定制可達(dá)更高

• 精準(zhǔn)控制海拔上升率、維持高度、持續(xù)時(shí)間、下降速率

• 自動(dòng)完成降壓、穩(wěn)壓、升壓過(guò)程

2.溫度控制

-15℃~30℃，支持定制溫控范圍

3.燈光控制

• 標(biāo)配1000LuxLED全光譜冷白光，可設(shè)定光照強(qiáng)度和晝夜節(jié)律

• 標(biāo)配UVC紫外消殺系統(tǒng)

• 可定制多色高強(qiáng)度燈光系統(tǒng)

• 可選配寬范圍多分布紫外模擬裝置，支持定制多UV波長(zhǎng)組合方案，逼真模擬強(qiáng)輻射環(huán)境

4.多功能編程模式

5.多功能控制-模式

1. 低壓低氧

2. 低壓常氧（選配）

3. 常壓低氧（選配）

4. 低氧高CO₂（選配）

5. 常壓高氧（選配）

6. 高CO₂（選配）

技術(shù)特色

1. 10 英寸大觸摸屏控制

人性化界面，操作簡(jiǎn)單

2.全面參數(shù)監(jiān)控

• 10 + 環(huán)境參數(shù)檢測(cè)（可增配）

• 海拔、氧氣動(dòng)態(tài)曲線呈現(xiàn)

• 實(shí)時(shí)數(shù)據(jù)導(dǎo)出（CSV 格式﹚﹕直接對(duì)接實(shí)驗(yàn)報(bào)告，無(wú)需手動(dòng)記錄，提升科研效率

監(jiān)控參數(shù)（實(shí)時(shí)）：

1.CO₂濃度

2.壓力

3.海拔高度

4.溫度

5.濕度

6.O₂濃度

7.氧分壓

3.自動(dòng)化

無(wú)人值守，減少實(shí)驗(yàn)人員夜間 / 節(jié)假日值守成本，避免人為操作誤差

4.操作方式

自動(dòng)、手動(dòng)自由切換

5.軟硬件雙重報(bào)警

避免動(dòng)物實(shí)驗(yàn)樣本損失，保障實(shí)驗(yàn)安全性

6.視頻監(jiān)控

• 動(dòng)物狀態(tài)實(shí)時(shí)反饋

• 紅外監(jiān)控讓黑暗環(huán)境也一覽無(wú)余

• 支持合并行為學(xué)研究
  

應(yīng)用場(chǎng)景

高原環(huán)境模擬

• 低壓、低氧、紫外：可精準(zhǔn)復(fù)現(xiàn)不同海拔的低壓，低氧及紫外輻照條件，還原從平原到高原的 環(huán)境梯度變化

動(dòng)物造模

• 腦水腫、肺動(dòng)脈高壓、高原肺水腫：可構(gòu)建高原腦水腫、肺動(dòng)脈高壓、高原肺水腫等典型病理模型，支撐高原病發(fā)病機(jī)制的動(dòng)物實(shí)驗(yàn)研究

藥物研究

• 高原藥理、毒理學(xué)、藥物穩(wěn)定性研究、抗缺氧藥物研發(fā)、制劑研發(fā)：覆蓋高原藥藥理、毒理評(píng)估及抗缺氧藥物、制劑的穩(wěn)定性與功效性驗(yàn)證、加速高原相關(guān)藥物研發(fā)進(jìn)程

特殊領(lǐng)域研究

• 航天航空、特種醫(yī)學(xué)：能模擬 8000 米以上高海拔環(huán)境適配航天航空領(lǐng)域、同時(shí)支持長(zhǎng)期實(shí)驗(yàn)助力高原邊防、特種部隊(duì)的環(huán)境適應(yīng)與任務(wù)能力研究

婦產(chǎn)科學(xué)研究

• 高原妊娠與胎兒發(fā)育毒性研究：構(gòu)建孕鼠高原暴露模型，評(píng)估低氧對(duì)胎盤(pán)功能、胎兒神經(jīng)發(fā)育、出生缺陷的影響，支撐圍產(chǎn)醫(yī)學(xué)與生殖毒理學(xué)研究

聯(lián)合實(shí)驗(yàn)及特殊定制

定制拓展功能，提供集成式方案，助力科研降本增效

1.特殊環(huán)境模擬：高鹽、臭氧、藍(lán)光、高輻照、濕熱

2.運(yùn)動(dòng)監(jiān)測(cè)：低壓運(yùn)動(dòng)跑臺(tái)、強(qiáng)迫游泳

3.行為學(xué)研究：睡眠、進(jìn)食、飲水、三維活動(dòng)、位置偏好、社交等

4.動(dòng)物生理指標(biāo)監(jiān)測(cè)：脈搏血氧、體溫血壓、心率 / 心電功能監(jiān)測(cè)

5.呼吸、代謝功能檢測(cè)

6.其他：給藥采血功能

詳細(xì)參數(shù)表

客戶(hù)經(jīng)典案例

高原低壓低氧致腦水腫模型(Xue et al., 2023)

高原低壓低氧致認(rèn)知障礙模型 (Wang et al., 2023)

高原低壓低氧致失憶模型 (Jiang et al., 2024)

高原低氧致脂肪細(xì)胞內(nèi)鐵過(guò)載 (Zhang et al., 2022)

相關(guān)文獻(xiàn)

[1] Drekolia M K, Mettner J, Wang D, et al. Cystine import and oxidative catabolism fuel vascular growth and repair via nutrient-responsive histone acetylation[J]. Cell Metabolism (IF 30.9), 2025.

[2] Wu L W, Chen M, Jiang C Y, et al. Inactivation of AXL in Cardiac Fibroblasts Alleviates Right Ventricular Remodeling in Pulmonary Hypertension[J]. Advanced Science (IF 14.1), 2025: e08995.

[3] Lei R, Gu M, Li J, et al. Lipoic acid/trometamol assembled hydrogel as injectable bandage for hypoxic wound healing at high altitude[J]. Chemical Engineering Journal (IF 13.4), 2024, 489: 151499.

[4] Li Z, Li H, Qiao W, et al. Multi-omics dissection of high TWAS-active endothelial pathogenesis in pulmonary arterial hypertension: bridging single-cell heterogeneity, machine learning-driven biomarkers, and developmental reprogramming[J]. International Journal of Surgery (IF 10.1), 10.1097.

[5] Pei Y, Huang L, Wang T, et al. Bone marrow mesenchymal stem cells loaded into hydrogel/nanofiber composite scaffolds ameliorate ischemic brain injury[J]. Materials Today Advances (IF 10), 2023, 17: 100349.

[6] Wang Q, Liu J, Li R, et al. Macrophage κ-opioid receptor inhibits hypoxic pulmonary hypertension progression and right heart dysfunction via an SCD1-dependent anti-inflammatory response[J]. Genes & Diseases (IF 9.4), 2025: 101604.

[7] Wang Y, Zhang R, Chen Q, et al. PPARγ Agonist Pioglitazone Prevents Hypoxia-induced Cardiac Dysfunction by Reprogramming Glucose Metabolism[J]. International Journal of Biological Sciences, 2024, 20(11): 4297.

[8] Wang Y, Shen P, Wu Z, et al. Plasma Proteomic Profiling Reveals ITGA2B as a key regulator of heart health in high-altitude settlers[J]. Genomics, Proteomics & Bioinformatics, 2025: qzaf030.

[9] Lan Y, Zhao S, Song Y, et al. Physicochemical properties of selenized quinoa protein hydrolysate and its regulatory effects on neuroinflammation and gut microbiota in hypoxic mice[J]. Journal of Future Foods, 2025.

[10] Pan Z, Yao Y, Liu X, et al. Nr1d1 inhibition mitigates intermittent hypoxia-induced pulmonary hypertension via Dusp1-mediated Erk1/2 deactivation and mitochondrial fission attenuation[J]. Cell Death Discovery, 2024, 10(1): 459.

[11] Zhou Y, Ni Z, Liu J, et al. Gut Microbiota‐Associated Metabolites Affected the Susceptibility to Heart Health Abnormality in Young Migrants at High‐Altitude: Gut Microbiota and Associated Metabolites Impart Heart Health in Plateau[C]//Exploration. 2025: 20240332.

[12] Li C, Zhao Z, Jin J, et al. NLRP3-GSDMD-dependent IL-1β Secretion from Microglia Mediates Learning and Memory Impairment in a Chronic Intermittent Hypoxia-induced Mouse Model[J]. Neuroscience, 2024, 539: 51-65.

[13] Yang W, Li M, Ding J, et al. High-altitude hypoxia exposure inhibits erythrophagocytosis by inducing macrophage ferroptosis in the spleen[J]. Elife, 2024, 12: RP87496.

[14] You Z, Huang Q, Zeng L, et al. Rab26 promotes hypoxia-induced hyperproliferation of PASMCs by modulating the AT1R-STAT3-YAP axis[J]. Cellular and Molecular Life Sciences, 2025, 82(1): 1-16.

[15] Pei C, Shen Z, Wu Y, et al. Eleutheroside B Pretreatment Attenuates Hypobaric Hypoxia‐Induced High‐Altitude Pulmonary Edema by Regulating Autophagic Flux via the AMPK/mTOR Pathway[J]. Phytotherapy Research, 2024, 38(12): 5657-5671.

[16] Duan H, Han Y, Zhang H, et al. Eleutheroside B Ameliorates Cardiomyocytes Necroptosis in High-Altitude-Induced Myocardial Injury via Nrf2/HO-1 Signaling Pathway[J]. Antioxidants, 2025, 14(2): 190.

[17] Song J, Zheng J, Li Z, et al. Sulfur dioxide inhibits mast cell degranulation by sulphenylation of galectin-9 at cysteine 74[J]. Frontiers in Immunology, 2024, 15: 1369326.

[18] Jia N, Shen Z, Zhao S, et al. Eleutheroside E from pre-treatment of Acanthopanax senticosus (Rupr. etMaxim.) Harms ameliorates high-altitude-induced heart injury by regulating NLRP3 inflammasome-mediated pyroptosis via NLRP3/caspase-1 pathway[J]. International Immunopharmacology, 2023, 121: 110423.

[19] Huang Q, Han X, Li J, et al. Intranasal Administration of Acetaminophen-Loaded Poly (lactic-co-glycolic acid) Nanoparticles Increases Pain Threshold in Mice Rapidly Entering High Altitudes[J]. Pharmaceutics, 2025, 17(3): 341.

[20] Wu Y, Tang Z, Du S, et al. Oral quercetin nanoparticles in hydrogel microspheres alleviate high-altitude sleep disturbance based on the gut-brain axis[J]. International Journal of Pharmaceutics, 2024, 658: 124225.

[21] Zhou Z, Zhao Q, Huang Y, et al. Berberine ameliorates chronic intermittent hypoxia‐induced cardiac remodelling by preserving mitochondrial function, role of SIRT6 signalling[J]. Journal of Cellular and Molecular Medicine, 2024, 28(12): e18407.

[22] Shang W, Huang Y, Xu Z, et al. The impact of a high-carbohydrate diet on the cognitive behavior of mice in a low-pressure, low-oxygen environment[J]. Food & Function, 2025, 16(3): 1116-1129.

[23] Pei C, Jia N, Wang Y, et al. Notoginsenoside R1 protects against hypobaric hypoxia-induced high-altitude pulmonary edema by inhibiting apoptosis via ERK1/2-P90rsk-BAD ignaling pathway[J]. European Journal of Pharmacology, 2023, 959: 176065.

[24] Xie L, Wu Q, Huang H, et al. Neuroregulation of histamine of circadian rhythm disorder induced by chronic intermittent hypoxia[J]. European Journal of Pharmacology, 2025: 177662.

[25] Ding Y, Liu W, Zhang X, et al. Bicarbonate-Rich Mineral Water Mitigates Hypoxia-Induced Osteoporosis in Mice via Gut Microbiota and Metabolic Pathway Regulation[J]. Nutrients, 2025, 17(6): 998.

[26] Gu N, Shen Y, He Y, et al. Loss of m6A demethylase ALKBH5 alleviates hypoxia-induced pulmonary arterial hypertension via inhibiting Cyp1a1 mRNA decay[J]. Journal of Molecular and Cellular Cardiology, 2024.

[27] Luan X, Zhu D, Hao Y, et al. Qibai Pingfei Capsule ameliorated inflammation in chronic obstructive pulmonary disease (COPD) via HIF-1 α/glycolysis pathway mediated of BMAL1[J]. International Immunopharmacology, 2025, 144: 113636.

[28] Jiang H, Lu C, Wu H, et al. Decreased cold‐inducible RNA‐binding protein (CIRP) binding to GluRl on neuronal membranes mediates memory impairment resulting from prolonged hypobaric hypoxia exposure[J]. CNS Neuroscience & Therapeutics, 2024, 30(9): e70059.

[29] Chang P, Xu M, Zhu J, et al. Pharmacological Inhibition of Mitochondrial Division Attenuates Simulated High‐Altitude Exposure‐Induced Memory Impairment in Mice: [30] Involvement of Inhibition of Microglia‐Mediated Synapse Elimination[J]. CNS Neuroscience & Therapeutics, 2025, 31(6): e70473.

[30] Liu C, Qu D, Li C, et al. miR‐448‐3p/miR‐1264‐3p Participates in Intermittent Hypoxic Response in Hippocampus by Regulating Fam76b/hnRNPA2B1[J]. CNS Neuroscience & Therapeutics, 2025, 31(2): e70239.

[31] Wu L W, Chen M, Jiang D J, et al. TCF7 enhances pulmonary hypertension by boosting stressed natural killer cells and their interaction with pulmonary arterial smooth muscle cells[J]. Respiratory Research, 2025, 26(1): 202.

[32] Xie L, Wu Q, Huang H, et al. Neuroregulation of histamine of circadian rhythm disorder induced by chronic intermittent hypoxia[J]. European Journal of Pharmacology, 2025: 177662.

[33] Cai S, Li Z, Bai J, et al. Optimized oxygen therapy improves sleep deprivation-induced cardiac dysfunction through gut microbiota[J]. Frontiers in Cellular and Infection Microbiology, 2025, 15: 1522431.

[34] Wang X, Xie Y, Niu Y, et al. CX3CL1/CX3CR1 signal mediates M1-type microglia and accelerates high-altitude-induced forgetting[J]. Frontiers in Cellular Neuroscience, 2023, 17: 1189348.

[35] He Y, Wang Y, Duan H, et al. Pharmacological targeting of ferroptosis in hypoxia-induced pulmonary edema: therapeutic potential of ginsenoside Rg3 through activation of the PI3K/AKT pathway[J]. Frontiers in Pharmacology, 2025, 16: 1644436.

[36] Guo Y, Qin J, Sun R, et al. Molecular hydrogen promotes retinal vascular regeneration and attenuates neovascularization and neuroglial dysfunction in oxygen-induced retinopathy mice[J]. Biological Research, 2024, 57.

[37] Liu L, Zhang J, Song S, et al. Paraventricular nucleus neurons: important regulators of respiratory movement in mice with chronic intermittent hypoxia[J]. Annals of Medicine, 2025, 57(1): 2588664.

[38] Ma Q, Ma J, Cui J, et al. Oxygen enrichment protects against intestinal damage and gut microbiota disturbance in rats exposed to acute high-altitude hypoxia[J]. Frontiers in Microbiology, 2023, 14.

[39] Lan J, Lin J, Guo Y, et al. Sequencing and bioinformatics analysis of exosome-derived miRNAs in mouse models of pancreatic injury induced by OSA[J]. Frontiers in Physiology, 2025, 16: 1712442.

[40] Feng X, Li C, Zhang W, et al. Mechanism of retinal angiogenesis induced by HIF-1α and HIF-2α under hyperoxic conditions[J]. Scientific Reports, 2025, 15(1): 36049.

[41] Yao Y, Chen Y, Li Y, et al. TGM2 Enhances Hypobaric Hypoxia-mediated Brain Injury Via Regulating NLRP3/GSDMD Signaling[J]. Neurochemical Research, 2025, 50(6): 1-11.

[42] Yang A, Guo L, Zhang Y, et al. MFN2-mediated mitochondrial fusion facilitates acute hypobaric hypoxia-induced cardiac dysfunction by increasing glucose catabolism and ROS production[J]. Biochimica et Biophysica Acta (BBA)-General Subjects, 2023: 130413.

[43] Chu H, Jiang W, Zuo N, et al. Astrocyte activation: A key mediator underlying chronic intermittent hypoxia-induced cognitive dysfunction[J]. Sleep Medicine, 2025: 106692.

[44] Xu A, Huang F, Chen E, et al. Hyperbaric oxygen therapy attenuates heatstroke-induced hippocampal injury by inhibiting microglial pyroptosis[J]. International Journal of Hyperthermia, 2024, 41(1): 2382162.

[45] Zhang Z, Zheng X, He Y, et al. Hyperbaric oxygen ameliorates neuroinflammation in heat-stressed BV-2 microglial cells: potential involvement of EAAT2 regulation[J]. International Journal of Hyperthermia, 2025, 42(1): 2583133.

[46] Jinyu F, Huaicun L, Yanfei Z, et al. Nogo-A Protein Mediates Oxidative Stress and Synaptic Damage Induced by High-altitude Hypoxia in the Rat Hippocampus[J]. 2024.

[47] Su L, Ni T, Fan R, et al. An attention to the effect of intravitreal injection on the controls of oxygen-induced retinopathy mouse model[J]. Experimental Eye Research, 2024, 248: 110094.

[48] Xu Y, Xu J, Li J, et al. Interplay of HIF-1α, SMAD2, and VEGF signaling in hypoxic renal environments: impact on macrophage polarization and renoprotection[J]. Renal Failure, 2025, 47(1): 2561784.

[49] Zhang D, Bian W, Gao Z. Impact of Obstructive Sleep Apnea on Endometrial Function in Female Rats: Mechanism Exploration[J]. Nature and Science of Sleep, 2025: 2485-2499.

[50] Zhang N, Wei F, Ning S, et al. PPARγ Agonist Rosiglitazone and Antagonist GW9662: Antihypertensive Effects on Chronic Intermittent Hypoxia-Induced Hypertension in Rats[J]. Journal of Cardiovascular Translational Research, 2024: 1-13.

[51] Zhang Y, Zhang A, Yang J, et al. Hypoxic Mesenchymal Stem Cell Exosome‐Derived SLC25A3 Ameliorates Bronchopulmonary Dysplasia by Modulating Macrophage Polarization and Oxidative Stress[J]. Cell Biochemistry and Function, 2025, 43(12): e70152.

[52] Lan J, Wang Y, Liu C, et al. Genome-wide analysis of m6A-modified circRNAs in the mouse model of myocardial injury induced by obstructive sleep apnea[J]. BMC Pulmonary Medicine, 2025, 25(1): 158.

[53] Zhang L, Liu X, Wei Q, et al. Arginine attenuates chronic mountain sickness in rats via microRNA-144-5p[J]. Mammalian Genome, 2023, 34(1): 76-89.

[54] Wei J, Hu M, Chen X, et al. Hypobaric Hypoxia Aggravates Renal Injury by Inducing the Formation of Neutrophil Extracellular Traps through the NF-κB Signaling Pathway[J]. Current Medical Science, 2023: 1-9.

[55] Zhang L, Li J, Wan Q, et al. Intestinal stem cell-derived extracellular vesicles ameliorate necrotizing enterocolitis injury[J]. Molecular and Cellular Probes, 2025, 79: 101997.

[56] Liao Y, Ke B, Long X, et al. Abnormalities in the SIRT1-SIRT3 axis promote myocardial ischemia-reperfusion injury through ferroptosis caused by silencing the PINK1/Parkin signaling pathway[J]. BMC Cardiovascular Disorders, 2023, 23(1): 582.

[57] Wang M, Wen W, Chen Y, et al. TRPC5 channel participates in myocardial injury in chronic intermittent hypoxia[J]. Clinics, 2024, 79: 100368.

[58] Li J, Ye J. Chronic intermittent hypoxia induces cognitive impairment in Alzheimer’s disease mouse model via postsynaptic mechanisms[J]. Sleep and Breathing, 2024: 1-9.

[59] Binbin L I, Haizhen L I, Houhuang C, et al. Utilizing Hyperbaric Oxygen Therapy to Improve Cognitive Function in Patients With Alzheimer’s Disease by Activating Autophagy-Related Signaling Pathways[J]. Physiological Research, 2025, 74(1): 141.

[60] Han J, Wang L, Wang L, et al. 5-Hydroxytryptamine Limits Pulmonary Arterial Hypertension Progression by Regulating Th17/Treg Balance[J]. Biological and Pharmaceutical Bulletin, 2025, 48(5): 555-562.

[61] Nan L, Kaisi F, Mengzhen Z, et al. miR-375-3p targets YWHAB to attenuate intestine injury in neonatal necrotizing enterocolitis[J]. Pediatric Surgery International, 2024, 40(1): 63.

[62] Liu B, Zheng W, Tang C, et al. Scutellarein-containing novel formula attenuates hypoxia through inhibiting apoptosis[J]. 2025.

參考研究

高原疾病介紹

不同的海拔高度大氣壓和氧分壓的變化對(duì)比

*我公司可提供3Q驗(yàn)證，根據(jù)客戶(hù)的特殊應(yīng)用、特殊需求提供功能定制服務(wù)，也可以提供相關(guān)的實(shí)驗(yàn)服務(wù)。

 *此介紹及參數(shù)為產(chǎn)品基礎(chǔ)信息，可能滯后于產(chǎn)品更新，具體參數(shù)請(qǐng)與我司聯(lián)系。